News & Updates

Show Multimedia Only

Infertility treatment carries increased risk of stroke hospitalization

04 Sep 2023

Women who conceive following infertility treatment appear to have a higher likelihood of stroke-related hospitalization within 12 months of delivery as compared with those who spontaneously conceive, according to a study.

Infertility treatment carries increased risk of stroke hospitalization

04 Sep 2023

Oral anticoagulation not the best bet for patients with atrial high-rate episodes

04 Sep 2023 by

Patients with atrial high-rate episodes (AHRE) do not seem to benefit from anticoagulation with edoxaban, which has fallen short of reducing the composite outcome of stroke, systemic embolism, or cardiovascular death, according to the results of the NOAH-AFNET* 6 trial.

Oral anticoagulation not the best bet for patients with atrial high-rate episodes

04 Sep 2023

At which dose does cannabis become toxic to kids?

03 Sep 2023

Ingestion of tetrahydrocannabinol (THC) from edible cannabis at ≥1.7 mg/kg can lead to significant toxicity in young children, according to a study.

At which dose does cannabis become toxic to kids?

03 Sep 2023

Recaticimab delivers promising outcomes in non-FH, mixed hyperlipidaemia

01 Sep 2023 by

Monotherapy with recaticimab can significantly lower low-density lipoprotein cholesterol (LDL-C) levels in patients with nonfamilial hypercholesterolemia (non-FH) and mixed hyperlipidaemia, according to data from the phase III REMAIN-1 study presented at ESC 2023.

Recaticimab delivers promising outcomes in non-FH, mixed hyperlipidaemia

01 Sep 2023

Brolucizumab prolongs interval of anti-VEGF injections in nAMD patients

01 Sep 2023

Treatment with brolucizumab results in a longer interval between injections of antivascular endothelial growth factor (anti-VEGF) agents for most treatment-experienced eyes, especially those with shorter intervals before switching, while maintaining or improving visual acuity (VA), reports a study.

Brolucizumab prolongs interval of anti-VEGF injections in nAMD patients

01 Sep 2023

Dexamethasone superior to ranibizumab, methotrexate for recurrent uveitic ME

01 Sep 2023 by

Treatment with dexamethasone implant results in better outcomes for patients with persistent or recurrent uveitic macular edema (ME) at 12 weeks when compared with methotrexate or ranibizumab, a study has shown. The risk of intraocular pressure (IOP), however, is higher with dexamethasone, but elevations to levels of 30 mm Hg or more are rare.

Dexamethasone superior to ranibizumab, methotrexate for recurrent uveitic ME

01 Sep 2023

Original New Drug Application Approvals by US FDA (16-31 August 2023)

01 Sep 2023

New drug applications approved by US FDA as of 16-31 August 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-31 August 2023)

01 Sep 2023

Antibiotic use, resistance rates low after a decade of stewardship efforts in SG

31 Aug 2023 by

Ten years since the implementation of antimicrobial stewardship programmes (ASP) in Singapore, the use of several types of antibiotics has dropped, followed by reductions in antimicrobial resistance across several classes, as reported in a study.

Antibiotic use, resistance rates low after a decade of stewardship efforts in SG

31 Aug 2023

AI predicts blood concentration of quetiapine in patients with schizophrenia, depression

31 Aug 2023

A machine learning model that incorporates artificial intelligence (AI) techniques to predict the blood concentration of quetiapine is feasible for clinical medication guidance in patients with schizophrenia and depression, reports a real-world study.

AI predicts blood concentration of quetiapine in patients with schizophrenia, depression

31 Aug 2023

US FDA greenlights first pill for postpartum depression

31 Aug 2023 by

The US Food and Drug Administration (FDA) has approved the first oral medication for postpartum depression in adults, giving clinicians a new therapeutic option for this debilitating condition.

US FDA greenlights first pill for postpartum depression

31 Aug 2023

News & Updates

Filter by Specialty:

Specialty:

Infertility treatment carries increased risk of stroke hospitalization

Infertility treatment carries increased risk of stroke hospitalization

Oral anticoagulation not the best bet for patients with atrial high-rate episodes

Oral anticoagulation not the best bet for patients with atrial high-rate episodes

At which dose does cannabis become toxic to kids?

At which dose does cannabis become toxic to kids?

Recaticimab delivers promising outcomes in non-FH, mixed hyperlipidaemia

Recaticimab delivers promising outcomes in non-FH, mixed hyperlipidaemia

Brolucizumab prolongs interval of anti-VEGF injections in nAMD patients

Brolucizumab prolongs interval of anti-VEGF injections in nAMD patients

Dexamethasone superior to ranibizumab, methotrexate for recurrent uveitic ME

Dexamethasone superior to ranibizumab, methotrexate for recurrent uveitic ME

Original New Drug Application Approvals by US FDA (16-31 August 2023)

Original New Drug Application Approvals by US FDA (16-31 August 2023)

Antibiotic use, resistance rates low after a decade of stewardship efforts in SG

Antibiotic use, resistance rates low after a decade of stewardship efforts in SG

AI predicts blood concentration of quetiapine in patients with schizophrenia, depression

AI predicts blood concentration of quetiapine in patients with schizophrenia, depression

US FDA greenlights first pill for postpartum depression

US FDA greenlights first pill for postpartum depression